|
1
|
El-Salhy M, Mazzawi T, Hausken T and
Hatlebakk JG: Interaction between diet and gastrointestinal
endocrine cells. Biomed Rep. 4:651–656. 2016.PubMed/NCBI
|
|
2
|
El-Salhy M, Gilja OH, Gundersen D,
Hatlebakk JG and Hausken T: Duodenal chromogranin a cell density as
a biomarker for the diagnosis of irritable bowel syndrome.
Gastroenterol Res Pract. 2014:4628562014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Salhy M and Hausken T: The role of the
neuropeptide Y (NPY) family in the pathophysiology of inflammatory
bowel disease (IBD). Neuropeptides. 55:137–144. 2016. View Article : Google Scholar
|
|
4
|
El-Salhy M, Danielsson A, Stenling R and
Grimelius L: Colonic endocrine cells in inflammatory bowel disease.
J Intern Med. 242:413–419. 1997. View Article : Google Scholar
|
|
5
|
El-Salhy M, Gundersen D, Hatlebakk JG and
Hausken T: Chromogranin A cell density as a diagnostic marker for
lymphocytic colitis. Dig Dis Sci. 57:3154–3159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
El-Salhy M, Gundersen D, Hatlebakk JG and
Hausken T: High densities of serotonin and peptide YY cells in the
colon of patients with lymphocytic colitis. World J Gastroenterol.
18:6070–6075. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
El-Salhy M, Lomholt-Beck B and Gundersen
TD: High chromogranin A cell density in the colon of patients with
lymphocytic colitis. Mol Med Rep. 4:603–605. 2011.PubMed/NCBI
|
|
8
|
Moran GW, Pennock J and McLaughlin JT:
Enteroendocrine cells in terminal ileal Crohn's disease. J Crohn's
Colitis. 6:871–880. 2012. View Article : Google Scholar
|
|
9
|
Moran GW, Leslie FC and McLaughlin JT:
Crohn's disease affecting the small bowel is associated with
reduced appetite and elevated levels of circulating gut peptides.
Clin Nutr. 32:404–411. 2013. View Article : Google Scholar
|
|
10
|
Besterman HS, Mallinson CN, Modigliani R,
Christofides ND, Pera A, Ponti V, Sarson DL and Bloom SR: Gut
hormones in inflammatory bowel disease. Scand J Gastroenterol.
18:845–852. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
El-Salhy M, Mazzawi T, Gundersen D,
Hatlebakk JG and Hausken T: The role of peptide YY in
gastrointestinal diseases and disorders (Review). Int J Mol Med.
31:275–282. 2013.PubMed/NCBI
|
|
12
|
Hirotani Y, Mikajiri K, Ikeda K, Myotoku M
and Kurokawa N: Changes of the peptide YY levels in the intestinal
tissue of rats with experimental colitis following oral
administration of mesalazine and prednisolone. Yakugaku Zasshi.
128:1347–1353. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vona-Davis LC and McFadden DW: NPY family
of hormones: Clinical relevance and potential use in
gastrointestinal disease. Curr Top Med Chem. 7:1710–1720. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
El-Salhy M, Suhr O and Danielsson A:
Peptide YY in gastrointestinal disorders. Peptides. 23:397–402.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tari A, Teshima H, Sumii K, Haruma K,
Ohgoshi H, Yoshihara M, Kajiyama G and Miyachi Y: Peptide YY
abnormalities in patients with ulcerative colitis. Jpn J Med.
27:49–55. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sciola V, Massironi S, Conte D, Caprioli
F, Ferrero S, Ciafardini C, Peracchi M, Bardella MT and Piodi L:
Plasma chromogranin a in patients with inflammatory bowel disease.
Inflamm Bowel Dis. 15:867–871. 2009. View Article : Google Scholar
|
|
17
|
Bishop AE, Pietroletti R, Taat CW,
Brummelkamp WH and Polak JM: Increased populations of endocrine
cells in Crohn's ileitis. Virchows Arch A Pathol Anat Histopathol.
410:391–396. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Manocha M and Khan WI: Serotonin and GI
Disorders: An update on clinical and experimental studies. Clin
Transl Gastroenterol. 3:e132012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stoyanova II and Gulubova MV: Mast cells
and inflammatory mediators in chronic ulcerative colitis. Acta
Histochem. 104:185–192. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamamoto H, Morise K, Kusugami K, Furusawa
A, Konagaya T, Nishio Y, Kaneko H, Uchida K, Nagai H, Mitsuma T and
Nagura H: Abnormal neuropeptide concentration in rectal mucosa of
patients with inflammatory bowel disease. J Gastroenterol.
31:525–532. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Payer J, Huorka M, Duris I, Mikulecky M,
Kratochvílová H, Ondrejka P and Lukác L: Plasma somatostatin levels
in ulcerative colitis. Hepatogastroenterology. 41:552–553.
1994.PubMed/NCBI
|
|
22
|
Watanabe T, Kubota Y, Sawada T and Muto T:
Distribution and quantification of somatostatin in inflammatory
disease. Dis Colon Rectum. 35:488–494. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koch TR, Carney JA, Morris VA and Go VL:
Somatostatin in the idiopathic inflammatory bowel diseases. Dis
Colon Rectum. 31:198–203. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mazzawi T and El-Salhy M: Changes in small
intestinal chromogranin A-immunoreactive cell densities in patients
with irritable bowel syndrome after receiving dietary guidance. Int
J Mol Med. 37:1247–1253. 2016.PubMed/NCBI
|
|
25
|
El-Salhy M, Umezawa K, Hatlebakk JG and
Gilja OH: Abnormal differentiation of stem cells into
enteroendocrine cells in rats with DSS-induced colitis. Mol Med
Rep. In press.
|
|
26
|
Elson CO, Sartor RB, Tennyson GS and
Riddell RH: Experimental models of inflammatory bowel disease.
Gastroenterology. 109:1344–1367. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
El-Salhy M and Umezawa K: Treatment with
novel AP-1 and NF-κB inhibitors restores the colonic endocrine
cells to normal levels in rats with DSS-induced colitis. Int J Mol
Med. 37:556–564. 2016.PubMed/NCBI
|
|
28
|
El-Salhy M, Wendelbo IH, Gundersen D,
Hatlebakk JG and Hausken T: Evaluation of the usefulness of
colonoscopy with mucosal biopsies in the follow-up of TNBS-induced
colitis in rats. Mol Med Rep. 8:446–450. 2013.PubMed/NCBI
|
|
29
|
Ota E, Takeiri M, Tachibana M, Ishikawa Y,
Umezawa K and Nishiyama S: Synthesis and biological evaluation of
molecular probes based on the 9-methylstreptimidone derivative
DTCM-glutarimide. Bioorg Med Chem Lett. 22:164–167. 2012.
View Article : Google Scholar
|
|
30
|
Takeiri M, Tachibana M, Kaneda A, Ito A,
Ishikawa Y, Nishiyama S, Goto R, Yamashita K, Shibasaki S, Hirokata
G, et al: Inhibition of macrophage activation and suppression of
graft rejection by DTCM-glutarimide, a novel piperidine derived
from the antibiotic 9-methylstreptimidone. Inflamm Res. 60:879–888.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ishikawa Y, Tachibana M, Matsui C, Obata
R, Umezawa K and Nishiyama S: Synthesis and biological evaluation
on novel analogs of 9-methylstreptimidone, an inhibitor of
NF-kappaB. Bioorg Med Chem Lett. 19:1726–1728. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ueki S, Yamashita K, Aoyagi T, Haga S,
Suzuki T, Itoh T, Taniguchi M, Shimamura T, Furukawa H, Ozaki M, et
al: Control of allograft rejection by applying a novel nuclear
factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Transplantation. 82:1720–1727. 2006. View Article : Google Scholar
|
|
33
|
Matsumoto N, Ariga A, To-e S, Nakamura H,
Agata N, Hirano S, Inoue J and Umezawa K: Synthesis of NF-kappaB
activation inhibitors derived from epoxyquinomicin C. Bioorg Med
Chem Lett. 10:865–869. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Umezawa N, Matsumoto N, Iwama S, Kato N
and Higuchi T: Facile synthesis of peptide-porphyrin conjugates:
Towards artificial catalase. Bioorg Med Chem. 18:6340–6350. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hunter MM, Wang A, Hirota CL and McKay DM:
Neutralizing anti-IL-10 antibody blocks the protective effect of
tapeworm infection in a murine model of chemically induced colitis.
J Immunol. 174:7368–7375. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Khan WI and Ghia JE: Gut hormones:
Emerging role in immune activation and inflammation. Clin Exp
Immunol. 161:19–27. 2010.PubMed/NCBI
|
|
37
|
Margolis KG and Gershon MD: Neuropeptides
and inflammatory bowel disease. Curr Opin Gastroenterol.
25:503–511. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bampton PA and Dinning PG: High resolution
colonic manometry - what have we learnt? - A review of the
literature 2012. Curr Gastroenterol Rep. 15:3282013. View Article : Google Scholar
|
|
39
|
Ameri P and Ferone D: Diffuse endocrine
system, neuroendocrine tumors and immunity: What's new?
Neuroendocrinology. 95:267–276. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Farzi A, Reichmann F and Holzer P: The
homeostatic role of neuropeptide Y in immune function and its
impact on mood and behaviour. Acta Physiol (Oxf). 213:603–627.
2015. View Article : Google Scholar
|
|
41
|
Spångéus A, Forsgren S and el-Salhy M:
Does diabetic state affect co-localization of peptide YY and
enteroglucagon in colonic endocrine cells? Histol Histopathol.
15:37–41. 2000.PubMed/NCBI
|
|
42
|
Pyarokhil AH, Ishihara M, Sasaki M and
Kitamura N: The developmental plasticity of colocalization pattern
of peptide YY and glucagon-like peptide-1 in the endocrine cells of
bovine rectum. Biomed Res. 33:35–38. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mortensen K, Christensen LL, Holst JJ and
Orskov C: GLP-1 and GIP are colocalized in a subset of endocrine
cells in the small intestine. Regul Pept. 114:189–196. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
El-Salhy M, Wilander E and Grimelius L:
Immunocytochemical localization of gastric inhibitory peptide (GIP)
in the human foetal pancreas. Ups J Med Sci. 87:81–85. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Svendsen B and Holst JJ: Regulation of gut
hormone secretion. Studies using isolated perfused intestines.
Peptides. 77:47–53. 2016. View Article : Google Scholar
|
|
46
|
Svendsen B, Pedersen J, Albrechtsen NJ,
Hartmann B, Toräng S, Rehfeld JF, Poulsen SS and Holst JJ: An
analysis of cosecretion and coexpression of gut hormones from male
rat proximal and distal small intestine. Endocrinology.
156:847–857. 2015. View Article : Google Scholar
|
|
47
|
Egerod KL, Engelstoft MS, Grunddal KV,
Nøhr MK, Secher A, Sakata I, Pedersen J, Windeløv JA, Füchtbauer
EM, Olsen J, et al: A major lineage of enteroendocrine cells
coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not
somatostatin. Endocrinology. 153:5782–5795. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cardoso WV and Lü J: Regulation of early
lung morphogenesis: Questions, facts and controversies.
Development. 133:1611–1624. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Darlington GJ: Molecular mechanisms of
liver development and differentiation. Curr Opin Cell Biol.
11:678–682. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Fausto N, Campbell JS and Riehle KJ: Liver
regeneration. Hepatology. 43(Suppl 1): S45–S53. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Rawlins EL and Hogan BL: Ciliated
epithelial cell lifespan in the mouse trachea and lung. Am J
Physiol Lung Cell Mol Physiol. 295:L231–L234. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Barker N and Clevers H: Tracking down the
stem cells of the intestine: Strategies to identify adult stem
cells. Gastroenterology. 133:1755–1760. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Barker N, van de Wetering M and Clevers H:
The intestinal stem cell. Genes Dev. 22:1856–1864. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Barker N, van Es JH, Kuipers J, Kujala P,
van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H,
Peters PJ and Clevers H: Identification of stem cells in small
intestine and colon by marker gene Lgr5. Nature. 449:1003–1007.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Barker N, van Oudenaarden A and Clevers H:
Identifying the stem cell of the intestinal crypt: Strategies and
pitfalls. Cell Stem Cell. 11:452–460. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Cheng C, Chan AO, Hui WM and Lam SK:
Coping strategies, illness perception, anxiety and depression of
patients with idiopathic constipation: A population-based study.
Aliment Pharmacol Ther. 18:319–326. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Rawdon BB and Andrew A: Origin and
differentiation of gut endocrine cells. Histol Histopathol.
8:567–580. 1993.PubMed/NCBI
|
|
58
|
Hoffman J, Kuhnert F, Davis CR and Kuo CJ:
Wnts as essential growth factors for the adult small intestine and
colon. Cell Cycle. 3:554–557. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Korinek V, Barker N, Moerer P, van
Donselaar E, Huls G, Peters PJ and Clevers H: Depletion of
epithelial stem-cell compartments in the small intestine of mice
lacking Tcf-4. Nat Genet. 19:379–383. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Montgomery RK and Breault DT: Small
intestinal stem cell markers. J Anat. 213:52–58. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Potten CS1, Booth C, Tudor GL, Booth D,
Brady G, Hurley P, Ashton G, Clarke R, Sakakibara S and Okano H:
Identification of a putative intestinal stem cell and early lineage
marker; musashi-1. Differentiation. 71:28–41. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Kayahara T, Sawada M, Takaishi S, Fukui H,
Seno H, Fukuzawa H, Suzuki K, Hiai H, Kageyama R, Okano H and Chiba
T: Candidate markers for stem and early progenitor cells, Musashi-1
and Hes1, are expressed in crypt base columnar cells of mouse small
intestine. FEBS Lett. 535:131–135. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
He XC, Yin T, Grindley JC, Tian Q, Sato T,
Tao WA, Dirisina R, Porter-Westpfahl KS, Hembree M, Johnson T, et
al: PTEN-deficient intestinal stem cells initiate intestinal
polyposis. Nat Genet. 39:189–198. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yang Q, Bermingham NA, Finegold MJ and
Zoghbi HY: Requirement of Math1 for secretory cell lineage
commitment in the mouse intestine. Science. 294:2155–2158. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Jenny M, Uhl C, Roche C, Duluc I,
Guillermin V, Guillemot F, Jensen J, Kedinger M and Gradwohl G:
Neurogenin3 is differentially required for endocrine cell fate
specification in the intestinal and gastric epithelium. EMBO J.
21:6338–6347. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wang J, Cortina G, Wu SV, Tran R, Cho JH,
Tsai MJ, Bailey TJ, Jamrich M, Ament ME, Treem WR, et al: Mutant
neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med.
355:270–280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Lee CS, Perreault N, Brestelli JE and
Kaestner KH: Neurogenin 3 is essential for the proper specification
of gastric enteroendocrine cells and the maintenance of gastric
epithelial cell identity. Genes Dev. 16:1488–1497. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo
FJ, Leiter AB and Tsai MJ: Diabetes, defective pancreatic
morphogenesis, and abnormal enteroendocrine differentiation in
BETA2-neuroD-deficient mice. Genes Dev. 11:2323–2334. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ahlgren U, Jonsson J and Edlund H: The
morphogenesis of the pancreatic mesenchyme is uncoupled from that
of the pancreatic epithelium in IPF1/PDX1-deficient mice.
Development. 122:1409–1416. 1996.PubMed/NCBI
|
|
70
|
Schonhoff SE, Giel-Moloney M and Leiter
AB: Minireview: Development and differentiation of gut endocrine
cells. Endocrinology. 145:2639–2644. 2004. View Article : Google Scholar : PubMed/NCBI
|
